What does ACCURAMED do?

ACCURAMED is registered with the CBE as active in: Groothandel in farmaceutische producten. Private Limited, started on 18 April 2000, 1 establishment.

What is the address of ACCURAMED?

The registered office of ACCURAMED is located at Stadsbeemd 1212, 3545 Halen.

Is ACCURAMED still active?

Yes. According to the CBE (29 October 2026) ACCURAMED is active, legal situation “Normale toestand”, started on 18 April 2000.

Is ACCURAMED registered on Peppol?

Yes, ACCURAMED is registered on the Peppol network with ID 0208:0471628153.

What is the enterprise number of ACCURAMED?

The enterprise number of ACCURAMED is BE0471628153.

When was ACCURAMED founded?

ACCURAMED was founded on 18 April 2000.

Who are the directors of ACCURAMED?

According to the 2025 annual accounts, the directors of ACCURAMED are: Medical Holding BV, Micromatic.

Is ACCURAMED a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 18 April 2000; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did ACCURAMED make in 2025?

ACCURAMED posted a profit after taxes of € 4,432,668 in financial year 2025.

What is the revenue of ACCURAMED?

In its most recent annual accounts (2025), ACCURAMED reported revenue of € 23,605,726.

How much does an employee at ACCURAMED earn?

The average wage cost per full-time employee at ACCURAMED was € 98,600 in 2025: staff costs of € 2.9 million for 29.6 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does ACCURAMED have?

According to the 2025 annual accounts, ACCURAMED has 29.6 full-time equivalents (FTE).

ACCURAMED (Private Limited) - Halen - BE0471628153

Dossier ACCURAMED, printed on 29 October 2026 from databakkes.be/en/0471628153/accuramed. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

ACCURAMED from Halen, company number BE0471628153, closed financial year 2025 with a result of € 4.4 million after tax. For that financial year ACCURAMED recorded revenue of € 23.6 million and equity of € 21.5 million. Compared with financial year 2024, the result moved from € 3.3 million to € 4.4 million. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on May 26, 2026.

What it is worth Healthy

€ 21.5 million

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 4.4 million

▲ 36% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 2.2 million

▼ 1% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 4.4 million paid out

100 % of the profit went to the shareholders, mostly to Medical Holding (100 % of the shares). That is where the money ends up.

People and assets in 2025

Full-time equivalents

29.6

▲ 10.3 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost Staff costs are payroll only. Director pay sits with services and miscellaneous goods: € 2.7 million in 2025, together with rent, insurance, accountants and other services. The accounts do not split that further.

€ 2.9 million

▲ 42% vs 2024

€ 98,600 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 1.3 million

▼ 3% vs 2024

Of which on lease € 655,872.

Debts at end 2025

Bank debt ≈ 9 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 746,653

▼ 10% vs 2024

€ 80,897 is repaid this year. At this pace the long-term loan is gone in ≈ 9 years.

Owed to suppliers

€ 2.4 million

▲ 42% vs 2024

Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 58 days on average.

Taxes and wages

€ 695,286

▲ 82% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Revenue	€ 31,612,071 Revenue 2022: € 31,612,071 First fiscal year in the series	€ 13,976,359 Revenue 2023: € 13,976,359 ▼ 56% vs 2022 (€ 31,612,071) Unfavourable step	€ 17,379,952 Revenue 2024: € 17,379,952 ▲ 24% vs 2023 (€ 13,976,359) Favourable step	€ 23,605,726 Revenue 2025: € 23,605,726 ▲ 36% vs 2024 (€ 17,379,952) Favourable step	▲ 36%
Profit after taxes	€ 7,432,309 Profit after taxes 2022: € 7,432,309 First fiscal year in the series	€ 3,256,320 Profit after taxes 2023: € 3,256,320 ▼ 56% vs 2022 (€ 7,432,309) Unfavourable step	€ 3,251,938 Profit after taxes 2024: € 3,251,938 Unchanged (€ 3,256,320) Unfavourable step	€ 4,432,668 Profit after taxes 2025: € 4,432,668 ▲ 36% vs 2024 (€ 3,251,938) Favourable step	▲ 36%
Equity	€ 21,139,464 Equity 2022: € 21,139,464 First fiscal year in the series	€ 22,121,034 Equity 2023: € 22,121,034 ▲ 5% vs 2022 (€ 21,139,464) Favourable step	€ 21,489,534 Equity 2024: € 21,489,534 ▼ 3% vs 2023 (€ 22,121,034) Unfavourable step	€ 21,489,534 Equity 2025: € 21,489,534 Unchanged (€ 21,489,534) Unchanged
Total debts	€ 6,745,748 Total debts 2022: € 6,745,748 First fiscal year in the series	€ 5,650,097 Total debts 2023: € 5,650,097 ▼ 16% vs 2022 (€ 6,745,748) Favourable step	€ 7,503,737 Total debts 2024: € 7,503,737 ▲ 33% vs 2023 (€ 5,650,097) Unfavourable step	€ 10,242,806 Total debts 2025: € 10,242,806 ▲ 37% vs 2024 (€ 7,503,737) Unfavourable step	▲ 37%
Cash	€ 13,174,906 Cash 2022: € 13,174,906 First fiscal year in the series	€ 2,686,322 Cash 2023: € 2,686,322 ▼ 80% vs 2022 (€ 13,174,906) Unfavourable step	€ 2,264,493 Cash 2024: € 2,264,493 ▼ 16% vs 2023 (€ 2,686,322) Unfavourable step	€ 2,244,467 Cash 2025: € 2,244,467 ▼ 1% vs 2024 (€ 2,264,493) Unfavourable step	▼ 1%
Retained profit	€ 21,120,864 Retained profit 2022: € 21,120,864 First fiscal year in the series	€ 22,102,434 Retained profit 2023: € 22,102,434 ▲ 5% vs 2022 (€ 21,120,864) Favourable step	€ 21,470,934 Retained profit 2024: € 21,470,934 ▼ 3% vs 2023 (€ 22,102,434) Unfavourable step	€ 21,470,934 Retained profit 2025: € 21,470,934 Unchanged (€ 21,470,934) Unchanged
Dividend	€ 3,000,000 Dividend 2022: € 3,000,000 First fiscal year in the series	€ 2,274,750 Dividend 2023: € 2,274,750 ▼ 24% vs 2022 (€ 3,000,000) Unchanged	€ 3,883,438 Dividend 2024: € 3,883,438 ▲ 71% vs 2023 (€ 2,274,750) Unchanged	€ 4,432,668 Dividend 2025: € 4,432,668 ▲ 14% vs 2024 (€ 3,883,438) Unchanged	▲ 14%
Bank debt	€ 994,224 Bank debt 2022: € 994,224 First fiscal year in the series	€ 898,540 Bank debt 2023: € 898,540 ▼ 10% vs 2022 (€ 994,224) Favourable step	€ 825,826 Bank debt 2024: € 825,826 ▼ 8% vs 2023 (€ 898,540) Favourable step	€ 746,653 Bank debt 2025: € 746,653 ▼ 10% vs 2024 (€ 825,826) Favourable step	▼ 10%
Balance sheet total	€ 27,885,212 Balance sheet total 2022: € 27,885,212 First fiscal year in the series	€ 27,771,130 Balance sheet total 2023: € 27,771,130 Unchanged (€ 27,885,212) Unchanged	€ 28,993,270 Balance sheet total 2024: € 28,993,270 ▲ 4% vs 2023 (€ 27,771,130) Unchanged	€ 31,732,340 Balance sheet total 2025: € 31,732,340 ▲ 9% vs 2024 (€ 28,993,270) Unchanged	▲ 9%
Employees (FTE)	19.9 Employees (FTE) 2022: 19.9 First fiscal year in the series	20 Employees (FTE) 2023: 20 ▲ 0.1 vs 2022 (19.9) Unchanged	19.3 Employees (FTE) 2024: 19.3 ▼ 0.7 vs 2023 (20) Unchanged	29.6 Employees (FTE) 2025: 29.6 ▲ 10.3 vs 2024 (19.3) Unchanged	▲ 10.3

Key figures of ACCURAMED, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to ACCURAMED?

What happened at ACCURAMED in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

May 26, 2026 New annual accounts for financial year 2025: profit of € 4.4 million (▲ 36% vs 2024). Source: NBB ↗
2024 Medical Holding BV became a director. NBB
2021 Micromatic became a director. NBB
Jan 1, 2007 New establishment in Halen. KBO
Apr 18, 2000 Start of the company according to the CBE. KBO

In short

From € 7.4 million profit in 2022 to € 4.4 million profit in 2025.

Paid € 3.4 million in corporate taxes since 2022.

Best year ever: 2022, with € 7.4 million profit.

Paid out € 13.6 million in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Medical Holding 100%

The stake of Medical Holding comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

ACCURAMED

Clindia Benelux 100%

MML-Medical 100%

Behind ACCURAMED are Medical Holding BV and Micromatic. The shares are held by Medical Holding (100%). It owns 100% of Clindia Benelux and 100% of MML-Medical itself.

Directors

According to the 2025 annual accounts

Medical Holding BV

Managing director · represented by Filip Knez

Also active at: BeMedico, B &C° GROUP SERVICES, SMARTBLEACH INTERNATIONAL

since 2024

Micromatic

Managing director · represented by Karel Knez

Also active at: BeMedico, B &C° GROUP SERVICES, MediConsult, SMARTBLEACH INTERNATIONAL, Medical Holding

since 2021

Shareholders

Medical Holding

100%

Participations

Clindia Benelux

100%

MML-Medical

100%

Establishments

Establishment units

Physical locations of this company

Registered office

Stadsbeemd 1212

3545 Halen

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 3 companies are registered at this address.

All companies at this address →

MediConsult same network

€ 30,823 gross margin · 2025

Medical Holding same network

€ 2.6 million revenue · 2025

MEDICAL HOLDING PARTNERSHIP

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0471.628.153

VAT number

BE 0471.628.153

Registered office

Stadsbeemd 1212, 3545 Halen

Names & denominations

ACCURAMED

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

18 April 2000

Peppol

Active · Active since 1 Jan 2001

Activities · NACE

Groothandel in farmaceutische producten

Groothandel in farmaceutische en medische artikelen

Handelsbemiddeling in de groothandel in andere specifieke goederen

Handelsbemiddeling gespecialiseerd in overige goederen, n.e.g.

View on CBE Public ↗ Annual accounts (NBB) ↗

ACCURAMED

Financials

What happened to ACCURAMED?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions